No abstract available
Publication types
-
Clinical Trial, Phase II
-
Comparative Study
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ADP-ribosyl Cyclase 1 / antagonists & inhibitors
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / pharmacokinetics
-
Antibodies, Monoclonal / therapeutic use*
-
Erythrocyte Transfusion*
-
Female
-
Fever / chemically induced
-
Follow-Up Studies
-
Humans
-
Immunologic Factors / adverse effects
-
Immunologic Factors / therapeutic use*
-
Male
-
Membrane Glycoproteins / antagonists & inhibitors
-
Middle Aged
-
Myelodysplastic Syndromes / drug therapy*
-
Myelodysplastic Syndromes / epidemiology
-
Myelodysplastic Syndromes / therapy
-
Neutropenia / chemically induced
-
Pneumonia / chemically induced
-
Proof of Concept Study
-
Risk
-
Thrombocytopenia / chemically induced
Substances
-
Antibodies, Monoclonal
-
Immunologic Factors
-
Membrane Glycoproteins
-
daratumumab
-
CD38 protein, human
-
ADP-ribosyl Cyclase 1